Events

Recent advances in the treatment of presbyopia have focused on pharmacological agents as a novel therapeutic strategy that offers noninvasive, reversible options capable of enhancing depth of focus without altering the natural lens structure. As new and emerging pharmacological therapies...

Research revealing that overexpression of TL1A drives key pathological pathways in inflammatory bowel disease (IBD) has accelerated the development of biologic therapies aimed at inhibiting this ligand. Early studies of investigational anti-TL1A agents—including tulisokibart, afimkibart, and duvakitug—demonstrate encouraging outcomes in...

In this online, on-demand educational video, Gus Alva, MD, DFAPA; and Erin Crown, MHS, PA-C will discuss the utility of oral antipsychotics for the treatment of newly diagnosed and previously treated patients with schizophrenia. The expert faculty will review the...

This online, on-demand virtual symposium brings together renowned experts in glaucoma. In this educational program, these experts focus on interventional glaucoma, a more proactive management approach that aims to minimize the challenges associated with topical glaucoma management with the earlier...

This video-based program is designed for eye care professionals to explore the management of neovascular age-related macular degeneration (nAMD) or diabetic macular edema (DME) using newer anti-VEGF agents with the potential for extended treatment intervals. This program places the patient’s...

In this video-based program, a multispecialty expert panel provides perspectives on the diagnosis and treatment of metabolic dysfunction–associated steatotic liver disease (MASLD) and its progressive subtype, metabolic dysfunction–associated steatohepatitis (MASH), which pose a critical and escalating public health crisis, particularly...

Neovascular age-related macular degeneration (nAMD), diabetic macular edema (DME), and retinal vein occlusion (RVO) are significant drivers of vision loss in the United States, and they put substantial burdens on patients—both from the disease itself and the need for regular...

This online, on-demand virtual symposium brings together renowned experts in dry eye disease (DED). In this educational program, these experts use a case-based format to discuss the latest data regarding management of this disorder, share their perspectives and best practices,...

Activity Overview This on-demand video program features expert faculty in the field of psoriasis who review the consensus statement from the National Psoriasis Foundation (NPF) regarding on-treatment remission in plaque psoriasis (PsO). The faculty discuss definitions, the methodology for the...

Activity Overview This online, on-demand virtual symposium brings together experts in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD), an increasingly recognized inflammatory demyelinating disorder with distinct clinical, radiographic, and immunologic features. In this educational program, these experts share data and expert...